£50 million private placement of loan notes

RNS Number : 9213A
The MedicX Fund Limited
01 October 2015
 



 

 

For immediate release                                                                                    

1 October 2015

 

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

 

 

£50 million private placement of loan notes

 

Further to the announcement on 1 May 2015, MedicX Fund Limited (LSE: MXF), the specialist primary care infrastructure investor in modern purpose-built primary healthcare properties in the United Kingdom, confirms that it has completed the second drawdown of £25 million under the £50 million private placement of loan notes with Standard Life Investments Limited.

Including this facility the average all-in fixed rate of debt for the Fund is 4.45% with an average unexpired term of 15 years. Assuming the funds were fully drawn immediately with the proceeds invested in completion of existing properties under construction or purchase of new properties, adjusted gearing (the ratio of total debt to total assets in each case net of cash and cash equivalents) would be expected to be approximately 53.4%.

 

 

- End -

 

For further information please contact:

 

MedicX Fund                                                                   +44 (0) 1481 723 450

David Staples, Chairman

 

Octopus Healthcare Group                                               +44 (0) 1483 869 500

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

 

Buchanan                                                                        +44 (0) 20 7466 5000

Charles Ryland/Victoria Watkins

 

 

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 143 properties.

 

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the Octopus Healthcare Group. The Octopus Healthcare Group is a specialist investor, developer and manager of healthcare properties with 40 people operating across the UK.

 

The Company's website address is www.medicxfund.comNeither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

 

 

 

 

 

 

 

 

 

                                                     

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPKDDNKBDDFKK
UK 100

Latest directors dealings